A commercial artificial intelligence system correctly identified nearly 88% of screen-detected cancers and 45% of interval cancers, according to a major study published in Radiology. 

Findings from a new JAMA study highlight the importance of patient-provider discussions when determining screening interval and modality. 

If approved by the House, the MAMMO Act would launch a telemammography pilot program to broaden offerings for vets in rural areas, among other changes.

More than a dozen states have required private payers to cover digital breast tomosynthesis, producing a $39 decrease in average price for the exam. 

TMIST just recently reached 65,000 participants, surpassing the halfway mark toward its current goal of 128,905, organizers announced recently. 

The uncertainty among respondents occurred, despite all receiving their mammograms in facilities with density notifications, according to new research.

Accredited U.S. programs have reported sizable monthly screening deficits for lung, breast, and colorectal cancer, researchers reported recently. 

Financial terms were not disclosed, but the two said the funds will fuel future expansion of its AI-based products, used for reading, reporting and processing images.